Constellation Energy heads into its May 7 Q1 results with options markets flashing a notably defensive tilt — the strongest since early in the year.
The put/call ratio has climbed to 1.48, roughly 1.5 standard deviations above its 20-day average of 1.34. That sits well clear of the norm, even though it remains below the 52-week peak of 1.66, suggesting investors have been accumulating downside protection as the stock pushed higher through April. The move stands out because the stock itself has recovered sharply — up 18% over the past month to $321.05 and +4.3% on Monday alone. Heavy hedging into a strong rally points to unease about whether the Q1 numbers can sustain the price action.
Short sellers, by contrast, are not making an aggressive bet against the stock. SI as a percentage of free float is 3.3% — a modest level. It has drifted up around 6.5% over the past week, but the cost to borrow is just 0.40%, and borrow availability is wide, meaning the lending market faces no squeeze pressure. The ORTEX short score of 35 is mid-range and broadly stable. Shorts appear to be hedging rather than pressing a strong directional view.
The analyst community has been trimming targets while keeping constructive ratings — a pattern that defines the setup. Morgan Stanley cut its price target to $360 from $385 on April 21. TD Cowen lowered to $381 from $390 on May 4. Scotiabank moved from $481 to $441 on April 29. Every firm maintained its positive rating. The consensus mean target of $368 implies around 15% upside from current levels, and the stock's analyst recommendation differential ranks in the 92nd percentile. Bulls point to a long runway of EPS growth driven by nuclear production tax credit dynamics and rising power demand, with forward EPS estimates running from roughly $12.75 in 2027 to $16.43 in 2030. Bears focus on commodity price risk, higher maintenance costs, and the risk that hyperscaler demand for power — a key demand driver in the CEG narrative — may not materialise at the pace the market priced in last year.
Earnings history adds context worth noting. The two most recent confirmed prints each saw the stock fall sharply on the day: a 5.8% decline on April 28 and a 6.4% drop on the March 31 event, with that latter move extending to an 8.7% loss over the following five days. February 2025's Q4 report was a notable exception, with a 3.5% gain that held into the following week. The May 7 print is therefore a test of whether the company's nuclear and power-demand story can justify a stock that has reclaimed ground quickly after those drawdowns — with options traders already paying for insurance just in case history repeats.
See the live data behind this article on ORTEX.
Open CEG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
